Guardant Health (GH) Competitor Comparison
We are evaluating the key criteria listed to compare Guardant Health (GH) against its competitors in the Diagnostics & Research industry.
Market Capitalization
26 / 58Gross Profits
26 / 52Total Revenue
28 / 57EBITDA
55 / 56Free Cashflow
53 / 56Quick Ratio
8 / 57Earnings per Share
53 / 56Dividend yield
0 / 9Total Cash
6 / 57Performance 3 years
41 / 58Performance 5 years
42 / 58Performance 10 years
30 / 58Linearity 3 years
39 / 58Linearity 5 years
29 / 58Linearity 10 years
1 / 58Total Rank
46 / 58Dividend Rank
52 / 58Valuation Rank
23 / 58Piotroski Rank
41 / 58Muliplier Rank
47 / 58Quick Ratio - GH ranking 8 / 57
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.